KVUE · News · 20260804N

Acquisition / Partnership / Divestiture

Kenvue Inc. · 2026-08-04 · Importance 71 · Surprise 60

Kimberly-Clark is pursuing a roughly $40 billion acquisition of Kenvue, with closing expected in the fourth quarter of 2026. The transaction would combine Kimberly-Clark’s consumer products portfolio with Kenvue brands including Tylenol, Listerine, and Neutrogena. Kimberly-Clark is preparing to consolidate 6,000 applications and more than 15 enterprise-resource-planning systems ahead of the integration. The buyer expects digital, supply-chain, commercial, and information-technology integration to support cost savings and operating efficiencies.

Key facts